{"transactions":[{"id":998452,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":73104,"kind":"person","name":"Wright Richard M.","position":1,"cik":"0001646423","reported_name":"Wright Richard M.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Officer"}}],"security":"Incentive Stock Option","published_at":"2025-11-17T21:17:07.000Z","date":"2025-11-13","kind":"exercise","planned":false,"acquired":false,"shares":15750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% vested on June 16, 2023 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":7875,"derivative":{"exercise_price":22.48,"expiration_date":"2032-06-16","underlying":"Common Stock","underlying_shares":15750},"source":{"system":"sec-edgar","filing":"0001646423-25-000007","document":"form4-11172025_091104.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/744218/000164642325000007/form4-11172025_091104.xml","form_type":"4"}},{"id":998451,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":73104,"kind":"person","name":"Wright Richard M.","position":1,"cik":"0001646423","reported_name":"Wright Richard M.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Officer"}}],"security":"Incentive Stock Option","published_at":"2025-11-17T21:17:07.000Z","date":"2025-11-13","kind":"exercise","planned":false,"acquired":false,"shares":26672,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"As of June 18, 2024, the option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":10.38,"expiration_date":"2030-06-18","underlying":"Common Stock","underlying_shares":26672},"source":{"system":"sec-edgar","filing":"0001646423-25-000007","document":"form4-11172025_091104.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/744218/000164642325000007/form4-11172025_091104.xml","form_type":"4"}},{"id":998450,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":73104,"kind":"person","name":"Wright Richard M.","position":1,"cik":"0001646423","reported_name":"Wright Richard M.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Officer"}}],"security":"Incentive Stock Option","published_at":"2025-11-17T21:17:07.000Z","date":"2025-11-13","kind":"exercise","planned":false,"acquired":false,"shares":6876,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"As of June 13, 2022, the option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":9.0165,"expiration_date":"2028-06-13","underlying":"Common Stock","underlying_shares":6876},"source":{"system":"sec-edgar","filing":"0001646423-25-000007","document":"form4-11172025_091104.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/744218/000164642325000007/form4-11172025_091104.xml","form_type":"4"}},{"id":998449,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":73104,"kind":"person","name":"Wright Richard M.","position":1,"cik":"0001646423","reported_name":"Wright Richard M.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Officer"}}],"security":"Common Stock","published_at":"2025-11-17T21:17:07.000Z","date":"2025-11-13","kind":"sale","planned":false,"acquired":false,"shares":49298,"price":24.0005,"value":1183176.649,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.00 to $24.05 per share, inclusive. The reporting person undertakes to provide to Celldex Therapeutics, Inc., any security holder of Celldex Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein."}],"balance_after":20833,"source":{"system":"sec-edgar","filing":"0001646423-25-000007","document":"form4-11172025_091104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/744218/000164642325000007/form4-11172025_091104.xml","form_type":"4"}},{"id":998448,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":73104,"kind":"person","name":"Wright Richard M.","position":1,"cik":"0001646423","reported_name":"Wright Richard M.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Officer"}}],"security":"Common Stock","published_at":"2025-11-17T21:17:07.000Z","date":"2025-11-13","kind":"exercise","planned":false,"acquired":true,"shares":15750,"price":22.48,"value":354060.0,"ownership":{"direct":true},"balance_after":70131,"source":{"system":"sec-edgar","filing":"0001646423-25-000007","document":"form4-11172025_091104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/744218/000164642325000007/form4-11172025_091104.xml","form_type":"4"}},{"id":998447,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":73104,"kind":"person","name":"Wright Richard M.","position":1,"cik":"0001646423","reported_name":"Wright Richard M.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Officer"}}],"security":"Common Stock","published_at":"2025-11-17T21:17:07.000Z","date":"2025-11-13","kind":"exercise","planned":false,"acquired":true,"shares":26672,"price":10.38,"value":276855.36,"ownership":{"direct":true},"balance_after":54381,"source":{"system":"sec-edgar","filing":"0001646423-25-000007","document":"form4-11172025_091104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/744218/000164642325000007/form4-11172025_091104.xml","form_type":"4"}},{"id":998446,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":73104,"kind":"person","name":"Wright Richard M.","position":1,"cik":"0001646423","reported_name":"Wright Richard M.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Officer"}}],"security":"Common Stock","published_at":"2025-11-17T21:17:07.000Z","date":"2025-11-13","kind":"exercise","planned":false,"acquired":true,"shares":6876,"price":9.0165,"value":61997.454,"ownership":{"direct":true},"balance_after":27709,"source":{"system":"sec-edgar","filing":"0001646423-25-000007","document":"form4-11172025_091104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000164642325000007/form4-11172025_091104.xml","form_type":"4"}},{"id":1478180,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":73104,"kind":"person","name":"Wright Richard M.","position":1,"cik":"0001646423","reported_name":"Wright Richard M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR. VP & CCO"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2024-06-17T20:16:12.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 13, 2025 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":65000,"derivative":{"exercise_price":36.43,"exercise_date":"2025-06-13","expiration_date":"2034-06-13","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001415889-24-017177","document":"form4-06172024_080608.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924017177/form4-06172024_080608.xml","form_type":"4"}},{"id":1491048,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":73104,"kind":"person","name":"Wright Richard M.","position":1,"cik":"0001646423","reported_name":"Wright Richard M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR. VP & CCO"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2024-06-05T20:05:45.000Z","date":"2024-06-03","kind":"exercise","planned":false,"acquired":false,"shares":18375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"25% vested on June 16, 2023 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":23625,"derivative":{"exercise_price":22.48,"expiration_date":"2032-06-16","underlying":"Common Stock","underlying_shares":18375},"source":{"system":"sec-edgar","filing":"0001415889-24-015543","document":"form4-06052024_080641.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924015543/form4-06052024_080641.xml","form_type":"4"}},{"id":1491047,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":73104,"kind":"person","name":"Wright Richard M.","position":1,"cik":"0001646423","reported_name":"Wright Richard M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR. VP & CCO"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2024-06-05T20:05:45.000Z","date":"2024-06-03","kind":"exercise","planned":false,"acquired":false,"shares":28469,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% vested on June 17, 2022 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":13531,"derivative":{"exercise_price":28,"expiration_date":"2031-06-17","underlying":"Common Stock","underlying_shares":28469},"source":{"system":"sec-edgar","filing":"0001415889-24-015543","document":"form4-06052024_080641.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924015543/form4-06052024_080641.xml","form_type":"4"}},{"id":1491046,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":73104,"kind":"person","name":"Wright Richard M.","position":1,"cik":"0001646423","reported_name":"Wright Richard M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR. VP & CCO"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2024-06-05T20:05:45.000Z","date":"2024-06-03","kind":"exercise","planned":false,"acquired":false,"shares":20625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"As of June 19, 2023, the option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":2.78,"expiration_date":"2029-06-19","underlying":"Common Stock","underlying_shares":20625},"source":{"system":"sec-edgar","filing":"0001415889-24-015543","document":"form4-06052024_080641.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924015543/form4-06052024_080641.xml","form_type":"4"}},{"id":1491045,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":73104,"kind":"person","name":"Wright Richard M.","position":1,"cik":"0001646423","reported_name":"Wright Richard M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR. VP & CCO"}}],"security":"Common Stock","published_at":"2024-06-05T20:05:45.000Z","date":"2024-06-03","kind":"sale","planned":false,"acquired":false,"shares":19264,"price":33.9854,"value":654694.7456,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.815 to $34.20 per share, inclusive. The reporting person undertakes to provide to Celldex Therapeutics, Inc., any security holder of Celldex Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein."},{"field":"shares","element":"transactionShares","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.815 to $34.20 per share, inclusive. The reporting person undertakes to provide to Celldex Therapeutics, Inc., any security holder of Celldex Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.815 to $34.20 per share, inclusive. The reporting person undertakes to provide to Celldex Therapeutics, Inc., any security holder of Celldex Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein."}],"balance_after":20833,"source":{"system":"sec-edgar","filing":"0001415889-24-015543","document":"form4-06052024_080641.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924015543/form4-06052024_080641.xml","form_type":"4"}},{"id":1491044,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":73104,"kind":"person","name":"Wright Richard M.","position":1,"cik":"0001646423","reported_name":"Wright Richard M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR. VP & CCO"}}],"security":"Common Stock","published_at":"2024-06-05T20:05:45.000Z","date":"2024-06-03","kind":"sale","planned":false,"acquired":false,"shares":27580,"price":33.5264,"value":924658.112,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.81 to $33.81 per share, inclusive. The reporting person undertakes to provide to Celldex Therapeutics, Inc., any security holder of Celldex Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein."},{"field":"shares","element":"transactionShares","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.81 to $33.81 per share, inclusive. The reporting person undertakes to provide to Celldex Therapeutics, Inc., any security holder of Celldex Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.81 to $33.81 per share, inclusive. The reporting person undertakes to provide to Celldex Therapeutics, Inc., any security holder of Celldex Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein."}],"balance_after":40097,"source":{"system":"sec-edgar","filing":"0001415889-24-015543","document":"form4-06052024_080641.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924015543/form4-06052024_080641.xml","form_type":"4"}},{"id":1491043,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":73104,"kind":"person","name":"Wright Richard M.","position":1,"cik":"0001646423","reported_name":"Wright Richard M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR. VP & CCO"}}],"security":"Common Stock","published_at":"2024-06-05T20:05:45.000Z","date":"2024-06-03","kind":"exercise","planned":false,"acquired":true,"shares":18375,"price":22.48,"value":413070.0,"ownership":{"direct":true},"balance_after":67677,"source":{"system":"sec-edgar","filing":"0001415889-24-015543","document":"form4-06052024_080641.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924015543/form4-06052024_080641.xml","form_type":"4"}},{"id":1491042,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":73104,"kind":"person","name":"Wright Richard M.","position":1,"cik":"0001646423","reported_name":"Wright Richard M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR. VP & CCO"}}],"security":"Common Stock","published_at":"2024-06-05T20:05:45.000Z","date":"2024-06-03","kind":"exercise","planned":false,"acquired":true,"shares":28469,"price":28,"value":797132.0,"ownership":{"direct":true},"balance_after":49302,"source":{"system":"sec-edgar","filing":"0001415889-24-015543","document":"form4-06052024_080641.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924015543/form4-06052024_080641.xml","form_type":"4"}},{"id":1491041,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":73104,"kind":"person","name":"Wright Richard M.","position":1,"cik":"0001646423","reported_name":"Wright Richard M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR. VP & CCO"}}],"security":"Common Stock","published_at":"2024-06-05T20:05:45.000Z","date":"2024-06-03","kind":"exercise","planned":false,"acquired":true,"shares":20625,"price":2.78,"value":57337.5,"ownership":{"direct":true},"balance_after":20833,"source":{"system":"sec-edgar","filing":"0001415889-24-015543","document":"form4-06052024_080641.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924015543/form4-06052024_080641.xml","form_type":"4"}},{"id":1850854,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":73104,"kind":"person","name":"Wright Richard M.","position":1,"cik":"0001646423","reported_name":"Wright Richard M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR. VP & CCO"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2023-06-20T20:19:39.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 15, 2024 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":45000,"derivative":{"exercise_price":36.87,"exercise_date":"2024-06-15","expiration_date":"2033-06-15","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001415889-23-010048","document":"form4-06202023_080633.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588923010048/form4-06202023_080633.xml","form_type":"4"}},{"id":2183174,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":73104,"kind":"person","name":"Wright Richard M.","position":1,"cik":"0001646423","reported_name":"Wright Richard M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR. VP & CCO"}}],"security":"Incentive Stock Option","published_at":"2022-08-17T20:05:54.000Z","date":"2022-08-15","kind":"exercise","acquired":false,"shares":15328,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vested on June 18, 2021 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":26672,"derivative":{"exercise_price":10.38,"expiration_date":"2030-06-18","underlying":"Common Stock","underlying_shares":15328},"source":{"system":"sec-edgar","filing":"0001415889-22-008767","document":"form4-08172022_010827.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588922008767/form4-08172022_010827.xml","form_type":"4"}},{"id":2183173,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":73104,"kind":"person","name":"Wright Richard M.","position":1,"cik":"0001646423","reported_name":"Wright Richard M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR. VP & CCO"}}],"security":"Common Stock","published_at":"2022-08-17T20:05:54.000Z","date":"2022-08-15","kind":"sale","acquired":false,"shares":15328,"price":37.7119,"value":578048.0032,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.35 to $38.31 per share, inclusive. The reporting person undertakes to provide to Celldex Therapeutics, Inc., any security holder of Celldex Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein."}],"balance_after":208,"source":{"system":"sec-edgar","filing":"0001415889-22-008767","document":"form4-08172022_010827.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588922008767/form4-08172022_010827.xml","form_type":"4"}},{"id":2183172,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":73104,"kind":"person","name":"Wright Richard M.","position":1,"cik":"0001646423","reported_name":"Wright Richard M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR. VP & CCO"}}],"security":"Common Stock","published_at":"2022-08-17T20:05:54.000Z","date":"2022-08-15","kind":"exercise","acquired":true,"shares":15328,"price":10.38,"value":159104.64,"ownership":{"direct":true},"balance_after":15536,"source":{"system":"sec-edgar","filing":"0001415889-22-008767","document":"form4-08172022_010827.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588922008767/form4-08172022_010827.xml","form_type":"4"}},{"id":2229185,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":73104,"kind":"person","name":"Wright Richard M.","position":1,"cik":"0001646423","reported_name":"Wright Richard M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR. VP & CCO"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2022-06-17T20:19:23.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":42000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 16, 2023 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":42000,"derivative":{"exercise_price":22.48,"exercise_date":"2023-06-16","expiration_date":"2032-06-16","underlying":"Common Stock","underlying_shares":42000},"source":{"system":"sec-edgar","filing":"0001415889-22-006733","document":"form4-06172022_010604.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588922006733/form4-06172022_010604.xml","form_type":"4"}},{"id":2662452,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":73104,"kind":"person","name":"Wright Richard M.","position":1,"cik":"0001646423","reported_name":"Wright Richard M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & CCO"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2021-06-21T20:28:45.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":42000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 17, 2022 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":42000,"derivative":{"exercise_price":28,"exercise_date":"2022-06-17","expiration_date":"2031-06-17","underlying":"Common Stock","underlying_shares":42000},"source":{"system":"sec-edgar","filing":"0001179110-21-006909","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000117911021006909/edgar.xml","form_type":"4"}},{"id":2943741,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":73104,"kind":"person","name":"Wright Richard M.","position":1,"cik":"0001646423","reported_name":"Wright Richard M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & CCO"}}],"security":"Incentive Stock Option","published_at":"2020-12-16T21:30:15.000Z","date":"2020-12-14","kind":"exercise","acquired":false,"shares":9375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% vested on June 19, 2020 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":20625,"derivative":{"exercise_price":2.78,"expiration_date":"2029-06-19","underlying":"Common Stock","underlying_shares":9375},"source":{"system":"sec-edgar","filing":"0001179110-20-011996","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/744218/000117911020011996/edgar.xml","form_type":"4"}},{"id":2943740,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":73104,"kind":"person","name":"Wright Richard M.","position":1,"cik":"0001646423","reported_name":"Wright Richard M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & CCO"}}],"security":"Incentive Stock Option","published_at":"2020-12-16T21:30:15.000Z","date":"2020-12-14","kind":"exercise","acquired":false,"shares":11457,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"This option was previously reported as covering 275,000 shares at an exercise price of $0.6011 per share, but was adjusted to reflect the reverse stock split that occurred on February 8, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% vested on June 13, 2019 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This option was previously reported as covering 275,000 shares at an exercise price of $0.6011 per share, but was adjusted to reflect the reverse stock split that occurred on February 8, 2019."}],"balance_after":6876,"derivative":{"exercise_price":9.0165,"expiration_date":"2028-06-13","underlying":"Common Stock","underlying_shares":11457},"source":{"system":"sec-edgar","filing":"0001179110-20-011996","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/744218/000117911020011996/edgar.xml","form_type":"4"}},{"id":2943739,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":73104,"kind":"person","name":"Wright Richard M.","position":1,"cik":"0001646423","reported_name":"Wright Richard M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & CCO"}}],"security":"Common Stock","published_at":"2020-12-16T21:30:15.000Z","date":"2020-12-14","kind":"sale","acquired":false,"shares":9375,"price":18.6065,"value":174435.9375,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On February 8, 2019, the Company implemented a one-for-fifteen reverse stock split of the Company's issued and outstanding common stock, resulting in the reporting person's ownership of 208 shares of the Company's common stock."}],"balance_after":208,"source":{"system":"sec-edgar","filing":"0001179110-20-011996","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/744218/000117911020011996/edgar.xml","form_type":"4"}},{"id":2943738,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":73104,"kind":"person","name":"Wright Richard M.","position":1,"cik":"0001646423","reported_name":"Wright Richard M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & CCO"}}],"security":"Common Stock","published_at":"2020-12-16T21:30:15.000Z","date":"2020-12-14","kind":"exercise","acquired":true,"shares":9375,"price":2.78,"value":26062.5,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On February 8, 2019, the Company implemented a one-for-fifteen reverse stock split of the Company's issued and outstanding common stock, resulting in the reporting person's ownership of 208 shares of the Company's common stock."}],"balance_after":9583,"source":{"system":"sec-edgar","filing":"0001179110-20-011996","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/744218/000117911020011996/edgar.xml","form_type":"4"}},{"id":2943737,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":73104,"kind":"person","name":"Wright Richard M.","position":1,"cik":"0001646423","reported_name":"Wright Richard M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & CCO"}}],"security":"Common Stock","published_at":"2020-12-16T21:30:15.000Z","date":"2020-12-14","kind":"sale","acquired":false,"shares":11457,"price":18.6065,"value":213174.6705,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On February 8, 2019, the Company implemented a one-for-fifteen reverse stock split of the Company's issued and outstanding common stock, resulting in the reporting person's ownership of 208 shares of the Company's common stock."}],"balance_after":208,"source":{"system":"sec-edgar","filing":"0001179110-20-011996","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/744218/000117911020011996/edgar.xml","form_type":"4"}},{"id":2943736,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":73104,"kind":"person","name":"Wright Richard M.","position":1,"cik":"0001646423","reported_name":"Wright Richard M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & CCO"}}],"security":"Common Stock","published_at":"2020-12-16T21:30:15.000Z","date":"2020-12-14","kind":"exercise","acquired":true,"shares":11457,"price":9.0165,"value":103302.0405,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This option was previously reported as covering 275,000 shares at an exercise price of $0.6011 per share, but was adjusted to reflect the reverse stock split that occurred on February 8, 2019."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On February 8, 2019, the Company implemented a one-for-fifteen reverse stock split of the Company's issued and outstanding common stock, resulting in the reporting person's ownership of 208 shares of the Company's common stock."}],"balance_after":11665,"source":{"system":"sec-edgar","filing":"0001179110-20-011996","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000117911020011996/edgar.xml","form_type":"4"}},{"id":3104882,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":73104,"kind":"person","name":"Wright Richard M.","position":1,"cik":"0001646423","reported_name":"Wright Richard M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & CCO"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2020-06-19T12:05:53.000Z","date":"2020-06-18","kind":"grant","acquired":true,"shares":42000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2008 Stock Option and Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 18, 2021 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":42000,"derivative":{"exercise_price":10.38,"exercise_date":"2021-06-18","expiration_date":"2030-06-18","underlying":"Common Stock","underlying_shares":42000},"source":{"system":"sec-edgar","filing":"0001179110-20-007593","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000117911020007593/edgar.xml","form_type":"4"}},{"id":3483588,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":73104,"kind":"person","name":"Wright Richard M.","position":1,"cik":"0001646423","reported_name":"Wright Richard M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & CCO"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2019-06-20T20:29:03.000Z","date":"2019-06-19","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2008 Stock Option and Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 19, 2020 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":30000,"derivative":{"exercise_price":2.78,"exercise_date":"2020-06-19","expiration_date":"2029-06-19","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001179110-19-007978","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000117911019007978/edgar.xml","form_type":"4"}},{"id":3893271,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":73104,"kind":"person","name":"Wright Richard M.","position":1,"cik":"0001646423","reported_name":"Wright Richard M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & CCO"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2018-06-15T11:46:34.000Z","date":"2018-06-13","kind":"grant","acquired":true,"shares":275000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2008 Stock Option and Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 13, 2019 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":275000,"derivative":{"exercise_price":0.6011,"exercise_date":"2019-06-13","expiration_date":"2028-06-13","underlying":"Common Stock","underlying_shares":275000},"source":{"system":"sec-edgar","filing":"0001179110-18-008566","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000117911018008566/edgar.xml","form_type":"4"}},{"id":4280095,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":73104,"kind":"person","name":"Wright Richard M.","position":1,"cik":"0001646423","reported_name":"Wright Richard M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & CCO"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2017-06-16T13:27:48.000Z","date":"2017-06-15","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2008 Stock Option and Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 15, 2018 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":75000,"derivative":{"exercise_price":2.32,"exercise_date":"2018-06-15","expiration_date":"2027-06-15","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001179110-17-009157","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000117911017009157/edgar.xml","form_type":"4"}}]}